MedPath

A randomized, double-blind, vehicle-controlled, half-side comparison, monocenter, clinical study evaluating the efficacy and safety of a herbal dermatitis ointment for the treatment of mild to moderate atopic dermatitis

Conditions
atopic dermatitis
Registration Number
EUCTR2004-002594-23-DE
Lead Sponsor
Weber & Weber GmbH & Co.KG
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Caucasian males and females betwen 18 and 65 years of age with mild to moderate atopic dermatitis
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Use of glucocorticoids 4 weeks prior to study entry
Systemic use of antihistamines, antipruritics or immunosuppressants 2 weeks prior to study entry
Any treatment of target area for at least 2 weeks prior to study entry

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: To evaluate the efficacy and safety of an herbal ointment in mild to moderate atopic dermatitis in adults;Secondary Objective: ;Primary end point(s): Local SCORAD: summary score for erythema, edema/papulation, oozing/crust, excoriation and lichenification (4 point scale)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath